Kenshoo to Acquire Signals Analytics to Fuel Intelligent Go-to-Market for Brands.
Supercharge your analytics and tap into a vast data ecosystem with our award-winning platform. Be in tune with your customer and gain a broad understanding of the market with actionable intelligence that drives decisions based on evidence, not opinion.
"AI-powered data analytics tools, like Signals Analytics, help us drive innovation forward with even more agility and speed. We are able to deliver breakthrough prestige beauty products to our consumers by blending our legendary creativity and product expertise with continuously updated quantitative insights and emerging trends."
"Signals Analytics is a leader in innovation/trends identification across industries. Their platform provides a strong data foundation, comprehensive proprietary data ocean, built-in AI contextual engines, and a highly-flexible framework (bringing all your internal and external data together). Built with over a decade of thought leadership and execution, their next-generation advanced analytics platform will drive significant business impact on your top and bottom line!"
"Signals Analytics’ ability to connect multiple external data sources into a single advanced analytics platform will empower and bring value to the mutual companies that we serve. Through our partnership, we are fueling a smarter market."
"The ability of AI to fuel drug development for complex conditions and rare diseases and drive commercial success makes platforms like Signals Analytics critical for managing business lifecycle decisions."
"Signals Analytics gives us the confidence to make the right business decisions by providing a 360-degree view of all the influences that may impact future demand from customer sentiment to market innovations."
"Unlike competitors that offer analytics that require data collection and customization, Signals Analytics delivers a configurable data platform that has already ingested more than 13,000 different data sources. It includes curated taxonomies and more than 100 analytic models, all of which can be adapted to the needs of the business.
The company employs a rich natural language processing (NLP) core to facilitate contextual research insights that can drive critical business decisions in a more timely and accurate manner. In the pharmaceutical arena, some of the data sources that are harmonized for analysis include clinical trial data, research publications, patents, company profiles, products, and financials, among several others."
